According to Rueters and news sources, here are at least three Bigpharma suitors (Pfizer, Novartis, and Abbott Labs looking to buy Brazil's Ache Laboratorios Farmaceuticos. Ache is a private firm, but there is a private auction for the firm apparently valued at $4 to $5 Billion. GSK (GlaxoSmithKline) was interested but dropped out of the running according to news sources. Others sources say the company is not for sale.
If any of these three are successful in bidding for Brazil Ache then you can be assured their will be an increase in diagnosis of psychiatric disorders in South America. We are sure you will see an increase in ADHD, depression, and autism. When the drug pushers need to cover their costs then they need an increase in “diagnosis” from doctors. Pharma sales reps commonly offer incentives (vacations, kickbacks etc) to get doctors to make the diagnosis to sell the drugs. A number of BigPharma firm and recently Abbott Labs were fined $1.6 Billion by the U.S. Dept. of Justice for marketing drugs for which the drugs was not approved to be marketed for. GSK(GlaxoSmithKline) was criminally indicted last year and fined $3Billion last year for selling drugs for off label purposes.
They obviously need to increase their footprint in South America to offset those fines.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment